Page 182 - Read Online
P. 182

Chen et al. Mini-invasive Surg 2018;2:42  I  http://dx.doi.org/10.20517/2574-1225.2018.59                                         Page 9 of 17


               but returned to baseline by 26 weeks. Anorectal function was worse at 6 weeks after surgery but returned
               to preoperative function at 12 weeks. Urinary function was not affected at any point after surgery. The
               study concluded that TEM has a transient and reversible impact on quality of life and anorectal function,
                                            [41]
               without affecting urinary function .
               TEM has also been studied as a treatment after neoadjuvant chemotherapy and radiation. In a study
               comparison between 31 patients with T2 and T3 rectal cancer who underwent either TEM vs. laparoscopic
               TME after neoadjuvant therapy, the authors found that the TEM resulted in better body image (P = 0.006),
                                                                                          [42]
               defecation function (P = 0.01) and weight loss (P = 0.005) than the laparoscopic group . At one month
               after surgery, the TEM group had better symptoms in terms of nausea, vomiting, appetite loss, and
               constipation compared to the laparoscopic group. At 6 months, the laparoscopic group had significantly
               worse global health status, emotional function, insomnia, and appetite loss, body image, and defecation
               problems. At one year, the TEM group showed better body image, defecation problems and weight loss
                                              [42]
               compared to the laparoscopic group .

               A summary of studies examining quality of life after TEM for rectal cancer is found in Table 3.

               TAMIS
               TAMIS emerged recently as an alternative to TEM. A flexible transanal multichannel laparoscopic port is
               used that is shorter in length than the conventional TEM rectoscope. Advocates state the benefit of TAMIS
               as being easier to learn for surgeons who are already proficient in laparoscopy, and more readily available
               because no specialized insufflators are needed. Furthermore, the flexible TAMIS platform is lower in cost
               and requires less time to setup than TEM. Contrary to TEM which uses a long rectoscope and insufflation,
               the TAMIS technique depends entirely on adequate insufflation for maximal exposure due to the short
               length of the port. Similar to TEM, TAMIS does not include a TME, and therefore usually yields no nodal
               information. Existing data suggests that TAMIS and TEM both only be performed for rectal adenomas and
               low risk T1N0 rectal cancers, and patients who refuse proctectomy. If final pathology does reveal high risk
               features, positive margins, high tumor grade, then a salvage TME or adjuvant therapy may be needed.

               In 2016, a short-term single-center study followed 24 patients with rectal adenomas and low risk T1 cancers
               with a median tumor height of 8 cm from the anal verge from 2011 to 2013 before TAMIS and 6 months
                                 [43]
               afterwards (2-17 cm) . In total, there were 20 adenomas and 4 low risk T1 cancers. Functional outcomes
               were assessed with the fecal incontinence severity index (FISI), and fecal incontinence quality of life (FIQL),
               and the generic EuroQol EQ-5D questionnaire. FISI and FIQL scores were unchanged from baseline at 6
                                                    [43]
                                                                        [44]
               months, and EQ-5D improved at 6 months . García-Flórez et al.  followed 32 patients who underwent
               TAMIS over a 40 months period. These patients were not given quality of life questionnaires but ques-
               tioned during clinic visit. Four weeks after surgery, 5 patients (15%) complained of minor fecal inconti-
               nence to flatus or liquid stool. However, by eight weeks after surgery the incontinence resolved. No urinary
               or sexual dysfunction was affected. This study revealed that TAMIS resulted in good short-term and long-
                                                       [44]
               term functional outcomes comparable to TEM .

               Another study published in 2018 compared 37 patients who underwent a TAMIS between 2011 and 2014,
               and then compared their quality of life outcomes to 37 matched healthy controls to the same age, gender,
                                      [45]
               and socio-economic status . Questionnaires including the SF-36 and FISI questionnaire were given after
               a median follow-up duration of 36 months to patients with either adenomas or T1 carcinomas. They found
               that TAMIS resulted in impaired social function. This worsening was attributed possibly to the fecal incon-
               tinence that occurred in 70% of the patients who underwent TAMIS. The FISI score worsened from 8.3 points
               pre-operatively to 10.1 points 3 years after this study. TAMIS patients reported an overall similar quality
               of life in comparison to their counterparts. TAMIS patients scored a higher mental health and bodily pain
   177   178   179   180   181   182   183   184   185   186   187